PubRank

Frank P T Hamers

Author PubWeight™ 25.99‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats. Ann Neurol 2005 2.22
2 Behavioral and histological characterization of unilateral cervical spinal cord contusion injury in rats. J Neurotrauma 2006 2.14
3 Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3. Development 2004 1.86
4 Human neural stem cells differentiate and promote locomotor recovery in an early chronic spinal cord injury NOD-scid mouse model. PLoS One 2010 1.66
5 Assessing behavioural function following a pyramidotomy lesion of the corticospinal tract in adult mice. Exp Neurol 2005 1.65
6 The assessment of locomotor function in spinal cord injured rats: the importance of objective analysis of coordination. J Neurotrauma 2005 1.52
7 Using the CatWalk method to assess weight-bearing and pain behaviour in walking rats with ankle joint monoarthritis induced by carrageenan: effects of morphine and rofecoxib. J Neurosci Methods 2008 1.26
8 Sciatic nerve regeneration in mice and rats: recovery of sensory innervation is followed by a slowly retreating neuropathic pain-like syndrome. Brain Res 2004 1.16
9 Suppression of fibrous scarring in spinal cord injury of rat promotes long-distance regeneration of corticospinal tract axons, rescue of primary motoneurons in somatosensory cortex and significant functional recovery. Eur J Neurosci 2005 1.15
10 Strain and locomotor speed affect over-ground locomotion in intact rats. Physiol Behav 2007 1.14
11 Locomotor recovery after spinal cord contusion injury in rats is improved by spontaneous exercise. J Neurotrauma 2003 1.03
12 Ex vivo adenoviral vector-mediated neurotrophin gene transfer to olfactory ensheathing glia: effects on rubrospinal tract regeneration, lesion size, and functional recovery after implantation in the injured rat spinal cord. J Neurosci 2003 1.03
13 Deficiency in complement C1q improves histological and functional locomotor outcome after spinal cord injury. J Neurosci 2008 1.01
14 Profound differences in spontaneous long-term functional recovery after defined spinal tract lesions in the rat. J Neurotrauma 2006 0.96
15 Ataxia with loss of Purkinje cells in a mouse model for Refsum disease. Proc Natl Acad Sci U S A 2008 0.94
16 Circulating insulin-like growth factor I and functional recovery from spinal cord injury under enriched housing conditions. Eur J Neurosci 2006 0.94
17 Activity-based therapies to promote forelimb use after a cervical spinal cord injury. J Neurotrauma 2009 0.91
18 Neuronal Ca2+ disregulation in diabetes mellitus. Eur J Pharmacol 2002 0.84
19 Systemic co-treatment with alpha-melanocyte stimulating hormone delays hearing loss caused by local cisplatin administration in guinea pigs. Hear Res 2003 0.78
20 Perilymphatic application of alpha-melanocyte stimulating hormone ameliorates hearing loss caused by systemic administration of cisplatin. Hear Res 2004 0.77
21 The potent melanocortin receptor agonist melanotan-II promotes peripheral nerve regeneration and has neuroprotective properties in the rat. Eur J Pharmacol 2003 0.77
22 Partial recovery of cisplatin-induced hearing loss in the albino guinea pig in relation to cisplatin dose. Hear Res 2002 0.76
23 Functional recovery, serotonergic sprouting, and endogenous progenitor fates in response to delayed environmental enrichment after spinal cord injury. J Neurotrauma 2011 0.76
24 Co-treatment with melanotan-II, a potent melanocortin, does not protect against cisplatin ototoxicity. Hear Res 2002 0.75